CN105343799A - Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition - Google Patents
Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition Download PDFInfo
- Publication number
- CN105343799A CN105343799A CN201510926411.8A CN201510926411A CN105343799A CN 105343799 A CN105343799 A CN 105343799A CN 201510926411 A CN201510926411 A CN 201510926411A CN 105343799 A CN105343799 A CN 105343799A
- Authority
- CN
- China
- Prior art keywords
- parts
- gout
- traditional chinese
- chinese medicinal
- medicinal composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicinal composition for treating gout and a preparation method of the traditional Chinese medicinal composition and relates to the field of traditional Chinese medicines. The traditional Chinese medicinal composition for treating the gout is prepared from the following components in parts by weight: 20 to 40 parts of rhizoma cibotii, 2 to 7 parts of lygodium japonicum, 8 to 15 parts of desmodium, 8 to 15 parts of pellodendron, 8 to 15 parts of cortex magnoliae officinalis, 8 to 15 parts of black bean, 2 to 7 parts of tuckahoe, 2 to 7 parts of schisandra chinensis, 2 to 7 parts of liquorice, 2 to 7 parts of pulsatilla chinensis regel, 2 to 7 parts of magnolia obavata, 2 to 7 parts of zedoary, 2 to 7 parts of tortoise plastron, 2 to 7 parts of alisma plantago-aquatica linn, 8 to 15 parts of dried orange peel, 2 to 7 parts of membrane of chicken gizzard, 2 to 7 parts of bulbus fritillariae cirrhosae, 2 to 7 parts of fructus amomi, 2 to 7 parts of dendrobe, 2 to 7 parts of myrrh and 8 to 15 parts of caulis spatholobi. Various raw materials are dried and crushed, and water is added into the crushed materials for decocting to obtain the traditional Chinese medicinal composition. The traditional Chinese medicinal composition for treating the gout, disclosed by the invention, is simple in preparation process and is significant in curative effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition.
Background technology
Gout is the crystal dependency arthrosis caused by monosodium urate salt (MSU) deposits, directly related with the hyperuricemia caused by purine metabolic disturbance and (or) underexcretion, refer in particular to acute characteristic arthritis and chronic gout stone disease.Along with the development of society, the quickening of rhythm of life, the increase of life stress, the change of dietary structure, patient with gout number is also in increase.Gout is more common in middle-aged male, and women only accounts for 5%, mainly postmenopausal women, and current gout has rejuvenation trend.The natural history of gout can be divided into the fourth phase, i.e. asymptomatic hyperuricemia phase, acute stage, intermission, chronic phase.The outbreak of gout brings considerable distress to patient.The Western medicine of general treatment gout has side effect more or less, and easily recurs, and gout is effected a radical cure.
Summary of the invention
For above-mentioned technical problem, the invention provides a kind of Chinese medicine composition for the treatment of gout and preparation method thereof.The Chinese medicine composition for the treatment of gout of the present invention is made up of the component of following weight portion: Rhizoma Cibotii 20 ~ 40 parts, Spora Lygodii 2 ~ 7 parts, Herba Lysimachiae 8 ~ 15 parts, Cortex Phellodendri 8 ~ 15 parts, Cortex Magnoliae Officinalis 8 ~ 15 parts, 8 ~ 15 parts, Semen sojae atricolor, 2 ~ 7 parts, Poria, Fructus Schisandrae Chinensis 2 ~ 7 parts, 2 ~ 7 parts, Radix Glycyrrhizae, the Radix Pulsatillae 2 ~ 7 parts, Cortex Magnoliae Officinalis 2 ~ 7 parts, Rhizoma Curcumae 2 ~ 7 parts, Carapax et Plastrum Testudinis 2 ~ 7 parts, Rhizoma Alismatis 2 ~ 7 parts, Pericarpium Citri Reticulatae 8 ~ 15 parts, Endothelium Corneum Gigeriae Galli 2 ~ 7 parts, Bulbus Fritillariae Cirrhosae 2 ~ 7 parts, Fructus Amomi 2 ~ 7 parts, Herba Dendrobii 2 ~ 7 parts, Myrrha 2 ~ 7 parts, Caulis Spatholobi 8 ~ 15 parts.
Further, the Chinese medicine composition for the treatment of gout of the present invention is made up of the component of following weight portion: Rhizoma Cibotii 25 ~ 35 parts, Spora Lygodii 4 ~ 6 parts, Herba Lysimachiae 9 ~ 12 parts, Cortex Phellodendri 9 ~ 12 parts, Cortex Magnoliae Officinalis 9 ~ 12 parts, 9 ~ 12 parts, Semen sojae atricolor, 4 ~ 6 parts, Poria, Fructus Schisandrae Chinensis 4 ~ 6 parts, 4 ~ 6 parts, Radix Glycyrrhizae, the Radix Pulsatillae 4 ~ 6 parts, Cortex Magnoliae Officinalis 4 ~ 6 parts, Rhizoma Curcumae 4 ~ 6 parts, Carapax et Plastrum Testudinis 4 ~ 6 parts, Rhizoma Alismatis 4 ~ 6 parts, Pericarpium Citri Reticulatae 9 ~ 12 parts, Endothelium Corneum Gigeriae Galli 4 ~ 6 parts, Bulbus Fritillariae Cirrhosae 4 ~ 6 parts, Fructus Amomi 4 ~ 6 parts, Herba Dendrobii 4 ~ 6 parts, Myrrha 4 ~ 6 parts, Caulis Spatholobi 9 ~ 12 parts.
Particularly, the Chinese medicine composition for the treatment of gout of the present invention is made up of the component of following weight portion: Rhizoma Cibotii 30 parts, Spora Lygodii 5 parts, Herba Lysimachiae 10 parts, Cortex Phellodendri 10 parts, Cortex Magnoliae Officinalis 10 parts, 10 parts, Semen sojae atricolor, 5 parts, Poria, Fructus Schisandrae Chinensis 5 parts, 5 parts, Radix Glycyrrhizae, the Radix Pulsatillae 5 parts, Cortex Magnoliae Officinalis 5 parts, Rhizoma Curcumae 5 parts, Carapax et Plastrum Testudinis 5 parts, Rhizoma Alismatis 5 parts, Pericarpium Citri Reticulatae 10 parts, Endothelium Corneum Gigeriae Galli 5 parts, Bulbus Fritillariae Cirrhosae 5 parts, Fructus Amomi 5 parts, Herba Dendrobii 5 parts, Myrrha 5 parts, Caulis Spatholobi 10 parts.
The preparation method of the Chinese medicine composition for the treatment of gout of the present invention is: by above-mentioned formula ratio, each raw material is cleaned, dry pulverizing after add in the water of 4 ~ 7 times of weight, decoct 40min ~ 2h, extraction fluid and insoluble matter, insoluble matter is added again in the water of 4 ~ 7 times of weight, decoct 2h ~ 5h, discard insoluble matter, merge extractive liquid, to obtain final product.
Particularly, by above-mentioned formula ratio, each raw material is cleaned, dry pulverizing after add in the water of 6 times of weight, decoct 1h, extraction fluid and insoluble matter, add in the water of 5 times of weight again by insoluble matter, decoct 3h, discard insoluble matter, merge extractive liquid, to obtain final product.
In key component of the present invention:
Rhizoma Cibotii bitter in the mouth, sweet, warm in nature.Return liver, kidney channel.Wind-damp dispelling, invigorating the liver and kidney, strong waist knee joint.For rheumatic arthralgia, soreness of the waist and knees, weakness of the lower extremities.
Herba Lysimachiae sweet in the mouth, salty, cold nature.Return liver, gallbladder, kidney, urinary bladder channel.Dampness removing jaundice eliminating, inducing diuresis for treating stranguria syndrome, removing toxic substances and promoting subsidence of swelling.For jaundice due to damp-heat, gallbladder-distention hypochondriac pain, stranguria caused by urinary stone, pyretic stranguria, difficulty and pain in micturition, carbuncle furuncle, snake bite and insect sting.
Cortex Phellodendri bitter in the mouth, cold in nature.Return kidney, urinary bladder channel.Have heat clearing and damp drying, pathogenic fire purging removes steams, effect of detoxification sore treatment.For damp-heat dysentery, jaundice dark coloured urine, leukorrhagia pudendal pruritus, the puckery pain of pyretic stranguria, beriberi flaccidity is knitted, hectic fever due to YIN-deficiency consumptive fever, night sweat, seminal emission, sore swollen toxin, eczema eczema.Stir-baked CORTEX PHELLODENDRI with salt solution nourishing YIN to lower pathogenic fire.For hyperactivity of fire caused by deficiency of YIN, night sweat hectic fever due to YIN-deficiency.
Cortex Magnoliae Officinalis bitter in the mouth, pungent, warm in nature, return spleen, stomach, lung, large intestine channel.Dampness expectorant, the therapeutic method to keep the adverse QI flowing downwards is except full.For humidity hysteresis damaging the spleen and stomach, gastral cavity painful abdominal mass is vomited and diarrhoea, and stagnation of QI due to dyspepsia, abdominal distention constipation, phlegm retention is breathed with cough.
Caulis Spatholobi sweet in the mouth, hardship, warm in nature, return liver, kidney channel, blood circulation promoting and enriching, menstruction regulating and pain relieving, relaxing muscles and tendons and activating QI and blood in the collateral.For menoxenia, dysmenorrhea, amenorrhea, rheumatic arthralgia, paralysis and numbness, blood deficiency and yellow complexion.
Semen sojae atricolor sweet in the mouth, cold nature, property is put down, enter spleen, kidney channel.The kidney invigorating tonifying YIN, invigorating spleen to remove dampness, except thermal detoxification.
Pericarpium Citri Reticulatae: bitter in the mouth, pungent, warm in nature.Return lung, spleen channel.Regulating qi-flowing for strengthening spleen, drying dampness to eliminate phlegm.For distension and fullness in the abdomen, lack of appetite and vomiting, cough with copious phlegm.
The Chinese medicine composition for the treatment of gout of the present invention take Rhizoma Cibotii as monarch drug, Herba Lysimachiae, Cortex Phellodendri, Pericarpium Citri Reticulatae, Cortex Magnoliae Officinalis, Caulis Spatholobi, Semen sojae atricolor are ministerial drug, Spora Lygodii, Poria, Fructus Schisandrae Chinensis, the Radix Pulsatillae, Cortex Magnoliae Officinalis, Rhizoma Curcumae, Carapax et Plastrum Testudinis, Rhizoma Alismatis, Endothelium Corneum Gigeriae Galli, Bulbus Fritillariae Cirrhosae, Fructus Amomi, Herba Dendrobii, Myrrha are adjuvant drug, and Radix Glycyrrhizae is for making medicine.By scientific compatibility, each flavour of a drug synergism, full side has rheumatic arthralgia, carbuncle sore tumefacting virus, heat-clearing and toxic substances removing, blood stasis dispelling damp eliminating, promoting blood circulation to remove obstruction in the collateral, the merit of reducing swelling and alleviating pain, can be used for treating the outbreak of various types of gout, and side effect is little.Preparation technology is simple, evident in efficacy.
In order to understand better and implement, the following detailed description of the present invention.
Detailed description of the invention
preparation embodiment 1
The Chinese medicine composition preparation method for the treatment of gout of the present invention is:
By weight, Rhizoma Cibotii 20 parts, Spora Lygodii 2 parts, Herba Lysimachiae 8 parts, Cortex Phellodendri 8 parts, Cortex Magnoliae Officinalis 8 parts, 8 parts, Semen sojae atricolor, 2 parts, Poria, Fructus Schisandrae Chinensis 2 parts, 2 parts, Radix Glycyrrhizae, the Radix Pulsatillae 2 parts, Cortex Magnoliae Officinalis 2 parts, Rhizoma Curcumae 2 parts, Carapax et Plastrum Testudinis 2 parts, Rhizoma Alismatis 2 parts, Pericarpium Citri Reticulatae 8 parts, Endothelium Corneum Gigeriae Galli 2 parts, Bulbus Fritillariae Cirrhosae 2 parts, Fructus Amomi 2 parts, Herba Dendrobii 2 parts, Myrrha 2 parts, Caulis Spatholobi 8 parts clean, dry pulverize after add in the water of 4 times of weight, decoct 40min, extraction fluid and insoluble matter, insoluble matter is added again in the water of 4 times of weight, decoct 2h, discard insoluble matter, merge extractive liquid, to obtain final product.
preparation embodiment 2
The Chinese medicine composition preparation method for the treatment of gout of the present invention is:
By weight, Rhizoma Cibotii 40 parts, Spora Lygodii 7 parts, Herba Lysimachiae 15 parts, Cortex Phellodendri 15 parts, Cortex Magnoliae Officinalis 15 parts, 15 parts, Semen sojae atricolor, 7 parts, Poria, Fructus Schisandrae Chinensis 7 parts, 7 parts, Radix Glycyrrhizae, the Radix Pulsatillae 7 parts, Cortex Magnoliae Officinalis 7 parts, Rhizoma Curcumae 7 parts, Carapax et Plastrum Testudinis 7 parts, Rhizoma Alismatis 7 parts, Pericarpium Citri Reticulatae 15 parts, Endothelium Corneum Gigeriae Galli 7 parts, Bulbus Fritillariae Cirrhosae 7 parts, Fructus Amomi 7 parts, Herba Dendrobii 7 parts, Myrrha 7 parts, Caulis Spatholobi 15 parts is cleaned, dry and add in the water of 7 times of weight after pulverizing, decoct 2h, extraction fluid and insoluble matter, insoluble matter is added again in the water of 7 times of weight, decoct 5h, discard insoluble matter, merge extractive liquid, obtain.
preparation embodiment 3
The Chinese medicine composition preparation method for the treatment of gout of the present invention is:
By weight, by Rhizoma Cibotii 25 parts, Spora Lygodii 4 parts, Herba Lysimachiae 9 parts, Cortex Phellodendri 9 parts, Cortex Magnoliae Officinalis 9 parts, 9 parts, Semen sojae atricolor, 4 parts, Poria, Fructus Schisandrae Chinensis 4 parts, 4 parts, Radix Glycyrrhizae, the Radix Pulsatillae 4 parts, Cortex Magnoliae Officinalis 4 parts, Rhizoma Curcumae 4 parts, Carapax et Plastrum Testudinis 4 parts, Rhizoma Alismatis 4 parts, Pericarpium Citri Reticulatae 9 parts, Endothelium Corneum Gigeriae Galli 4 parts, Bulbus Fritillariae Cirrhosae 4 parts, Fructus Amomi 4 parts, Herba Dendrobii 4 parts, Myrrha 4 parts, Caulis Spatholobi 9 parts clean, dry pulverize after add in the water of 6 times of weight, decoct 1h, extraction fluid and insoluble matter, insoluble matter is added again in the water of 6 times of weight, decoct 4h, discard insoluble matter, merge extractive liquid, to obtain final product.
preparation embodiment 4
The Chinese medicine composition preparation method for the treatment of gout of the present invention is:
By weight, by Rhizoma Cibotii 35 parts, Spora Lygodii 6 parts, Herba Lysimachiae 12 parts, Cortex Phellodendri 12 parts, Cortex Magnoliae Officinalis 12 parts, 12 parts, Semen sojae atricolor, 6 parts, Poria, Fructus Schisandrae Chinensis 6 parts, 6 parts, Radix Glycyrrhizae, the Radix Pulsatillae 6 parts, Cortex Magnoliae Officinalis 6 parts, Rhizoma Curcumae 6 parts, Carapax et Plastrum Testudinis 6 parts, Rhizoma Alismatis 6 parts, Pericarpium Citri Reticulatae 12 parts, Endothelium Corneum Gigeriae Galli 6 parts, Bulbus Fritillariae Cirrhosae 6 parts, Fructus Amomi 6 parts, Herba Dendrobii 6 parts, Myrrha 6 parts, Caulis Spatholobi 12 parts is cleaned, dry and add in the water of 5 times of weight after pulverizing, decoct 1.5h, extraction fluid and insoluble matter, insoluble matter is added again in the water of 5 times of weight, decoct 2.5h, discard insoluble matter, merge extractive liquid, obtain.
preparation embodiment 5
The Chinese medicine composition preparation method for the treatment of gout of the present invention is:
By weight, by Rhizoma Cibotii 30 parts, Spora Lygodii 5 parts, Herba Lysimachiae 10 parts, Cortex Phellodendri 10 parts, Cortex Magnoliae Officinalis 10 parts, 10 parts, Semen sojae atricolor, 5 parts, Poria, Fructus Schisandrae Chinensis 5 parts, 5 parts, Radix Glycyrrhizae, the Radix Pulsatillae 5 parts, Cortex Magnoliae Officinalis 5 parts, Rhizoma Curcumae 5 parts, Carapax et Plastrum Testudinis 5 parts, Rhizoma Alismatis 5 parts, Pericarpium Citri Reticulatae 10 parts, Endothelium Corneum Gigeriae Galli 5 parts, Bulbus Fritillariae Cirrhosae 5 parts, Fructus Amomi 5 parts, Herba Dendrobii 5 parts, Myrrha 5 parts, Caulis Spatholobi 10 parts is cleaned, dry and add in the water of 6 times of weight after pulverizing, decoct 1h, extraction fluid and insoluble matter, insoluble matter is added again in the water of 5 times of weight, decoct 3h, discard insoluble matter, merge extractive liquid, obtain.
case embodiment
1. Zhu, man, 42 years old, gout history 4 years, clinical manifestation is Metatarsophalangeal joint red and swollen heat pain, joint joint stuffiness, intraarticular nodosity, start the Chinese medicine composition taking the obtained treatment gout of the embodiment of the present invention 1 in February, 2015, every day 3 times, each 200ml, transference cure after March, continue to take drug withdrawal after 3 months, so far without recurrence, whole drug administration process is without any side effects.
2. Korea Spro, man, 34 years old, gout history 3 years, clinical manifestation is finger thumb joint redness, falls ill and within the 3rd day, starts to take the Chinese medicine composition of the obtained treatment gout of the embodiment of the present invention 2, every day 3 times, each 200ml, transference cure after 4 days, whole drug administration process is without any side effects.
3. what certain, man, 55 years old, gout history 9 years, clinical manifestation was big toe congestion and swelling pain outside right crus of diaphragm, joint deformity, the symptoms such as heating.Start the Chinese medicine composition taking the obtained treatment gout of the embodiment of the present invention 3 in March, 2015, every day 3 times, each 300ml, transference cure after March, continues to take drug withdrawal after 3 months, and so far without recurrence, whole drug administration process is without any side effects.
The present invention is not limited to above-mentioned embodiment, if do not depart from the spirit and scope of the present invention to various change of the present invention or distortion, if these are changed and distortion belongs within claim of the present invention and equivalent technologies scope, then the present invention is also intended to comprise these changes and distortion.
Claims (5)
1. treat a Chinese medicine composition for gout, it is characterized in that being made up of the component of following weight portion: Rhizoma Cibotii 20 ~ 40 parts, Spora Lygodii 2 ~ 7 parts, Herba Lysimachiae 8 ~ 15 parts, Cortex Phellodendri 8 ~ 15 parts, Cortex Magnoliae Officinalis 8 ~ 15 parts, 8 ~ 15 parts, Semen sojae atricolor, 2 ~ 7 parts, Poria, Fructus Schisandrae Chinensis 2 ~ 7 parts, 2 ~ 7 parts, Radix Glycyrrhizae, the Radix Pulsatillae 2 ~ 7 parts, Cortex Magnoliae Officinalis 2 ~ 7 parts, Rhizoma Curcumae 2 ~ 7 parts, Carapax et Plastrum Testudinis 2 ~ 7 parts, Rhizoma Alismatis 2 ~ 7 parts, Pericarpium Citri Reticulatae 8 ~ 15 parts, Endothelium Corneum Gigeriae Galli 2 ~ 7 parts, Bulbus Fritillariae Cirrhosae 2 ~ 7 parts, Fructus Amomi 2 ~ 7 parts, Herba Dendrobii 2 ~ 7 parts, Myrrha 2 ~ 7 parts, Caulis Spatholobi 8 ~ 15 parts.
2. the Chinese medicine composition for the treatment of gout according to claim 1, it is characterized in that being made up of the component of following weight portion: Rhizoma Cibotii 25 ~ 35 parts, Spora Lygodii 4 ~ 6 parts, Herba Lysimachiae 9 ~ 12 parts, Cortex Phellodendri 9 ~ 12 parts, Cortex Magnoliae Officinalis 9 ~ 12 parts, 9 ~ 12 parts, Semen sojae atricolor, 4 ~ 6 parts, Poria, Fructus Schisandrae Chinensis 4 ~ 6 parts, 4 ~ 6 parts, Radix Glycyrrhizae, the Radix Pulsatillae 4 ~ 6 parts, Cortex Magnoliae Officinalis 4 ~ 6 parts, Rhizoma Curcumae 4 ~ 6 parts, Carapax et Plastrum Testudinis 4 ~ 6 parts, Rhizoma Alismatis 4 ~ 6 parts, Pericarpium Citri Reticulatae 9 ~ 12 parts, Endothelium Corneum Gigeriae Galli 4 ~ 6 parts, Bulbus Fritillariae Cirrhosae 4 ~ 6 parts, Fructus Amomi 4 ~ 6 parts, Herba Dendrobii 4 ~ 6 parts, Myrrha 4 ~ 6 parts, Caulis Spatholobi 9 ~ 12 parts.
3. the Chinese medicine composition for the treatment of gout according to claim 2, is characterized in that being made up of the component of following weight portion: Rhizoma Cibotii 30 parts, Spora Lygodii 5 parts, Herba Lysimachiae 10 parts, Cortex Phellodendri 10 parts, Cortex Magnoliae Officinalis 10 parts, 10 parts, Semen sojae atricolor, 5 parts, Poria, Fructus Schisandrae Chinensis 5 parts, 5 parts, Radix Glycyrrhizae, the Radix Pulsatillae 5 parts, Cortex Magnoliae Officinalis 5 parts, Rhizoma Curcumae 5 parts, Carapax et Plastrum Testudinis 5 parts, Rhizoma Alismatis 5 parts, Pericarpium Citri Reticulatae 10 parts, Endothelium Corneum Gigeriae Galli 5 parts, Bulbus Fritillariae Cirrhosae 5 parts, Fructus Amomi 5 parts, Herba Dendrobii 5 parts, Myrrha 5 parts, Caulis Spatholobi 10 parts.
4. prepare the method for the Chinese medicine composition of the treatment gout described in claims 1 to 3 any one, it is characterized in that: by above-mentioned formula ratio, each raw material is cleaned, dry pulverizing after add in the water of 4 ~ 7 times of weight, decoct 40min ~ 2h, extraction fluid and insoluble matter, add in the water of 4 ~ 7 times of weight again by insoluble matter, decoct 2h ~ 5h, discard insoluble matter, merge extractive liquid, to obtain final product.
5. the preparation method of the Chinese medicine composition for the treatment of gout according to claim 4, it is characterized in that: by above-mentioned formula ratio, each raw material is cleaned, dry pulverizing after add in the water of 6 times of weight, decoct 1h, extraction fluid and insoluble matter, add in the water of 5 times of weight again by insoluble matter, decoct 3h, discard insoluble matter, merge extractive liquid, to obtain final product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510926411.8A CN105343799A (en) | 2015-12-14 | 2015-12-14 | Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510926411.8A CN105343799A (en) | 2015-12-14 | 2015-12-14 | Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105343799A true CN105343799A (en) | 2016-02-24 |
Family
ID=55319958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510926411.8A Pending CN105343799A (en) | 2015-12-14 | 2015-12-14 | Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105343799A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102240378A (en) * | 2010-05-10 | 2011-11-16 | 张金荣 | Pharmaceutical composition for treating gout and preparation method thereof |
CN104721645A (en) * | 2015-03-03 | 2015-06-24 | 刘正菊 | Traditional Chinese medicine composition for treating gout and preparation method of traditional Chinese medicine composition |
CN104740424A (en) * | 2013-12-30 | 2015-07-01 | 魏修彦 | A method of treating gout |
-
2015
- 2015-12-14 CN CN201510926411.8A patent/CN105343799A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102240378A (en) * | 2010-05-10 | 2011-11-16 | 张金荣 | Pharmaceutical composition for treating gout and preparation method thereof |
CN104740424A (en) * | 2013-12-30 | 2015-07-01 | 魏修彦 | A method of treating gout |
CN104721645A (en) * | 2015-03-03 | 2015-06-24 | 刘正菊 | Traditional Chinese medicine composition for treating gout and preparation method of traditional Chinese medicine composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105288518A (en) | Traditional Chinese medicine composition for treating gout and preparation method thereof | |
CN103520497B (en) | Chinese medicinal composition for treating gout and preparation method thereof | |
CN103705809A (en) | Traditional Chinese medicine for curing gout | |
CN103877286A (en) | Orally taken medicine for treating erysipelas and preparation method thereof | |
CN103800693A (en) | Traditional Chinese medicine preparation for treating chronic pharyngitis | |
CN103550345A (en) | Medicinal liquor for treating rheumatic pain | |
CN104707046A (en) | Traditional Chinese medicine for treating pelvic inflammation | |
CN103800697A (en) | Traditional Chinese medicine composition for treating pharyngitis | |
CN104042925A (en) | Traditional Chinese medicinal composition for treating gout and preparation method thereof | |
CN105435100A (en) | Traditional Chinese medicine composition for treating gout and preparation method thereof | |
CN1124337C (en) | Scorpion-centipede wine | |
CN104958520A (en) | Traditional Chinese medicine for treating osteoarthritis | |
CN105343799A (en) | Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition | |
CN104547941A (en) | Traditional Chinese medicine composition for preventing and treating cerebral thrombosis | |
CN104758668A (en) | Traditional Chinese medicine composition for treating tympanites with syndrome of accumulation and binding of water-heat | |
CN105343801A (en) | Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition | |
CN104547953A (en) | Traditional Chinese medicine composition for treating arthritis and preparation method thereof | |
CN105343802A (en) | Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition | |
CN105311586A (en) | Traditional Chinese medicine composition for treating gout and preparation method thereof | |
CN104491587B (en) | The medicament of the damage side reaction of hepatic and renal function caused by mitigating chemotherapy and preparation | |
CN105288519A (en) | Traditional Chinese medicine composition for treating gout and preparation method thereof | |
CN105362951A (en) | Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition | |
CN104689072A (en) | TCM (Traditional Chinese Medicine) composition for treating blood stasis binding and water retention type tympany | |
CN105125836A (en) | Decoction medicament for treating erythema nodosum and preparation method thereof | |
CN105853933A (en) | Traditional Chinese medicine preparation for treating postoperative recurrence and metastasis of breast cancer and preparing method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160224 |
|
WD01 | Invention patent application deemed withdrawn after publication |